The dual identity of a bacterium: From lab hero to hospital hazard

Health · Published 18 October 2026 Swipe more like this →

In short: Pseudomonas putida is a biological paradox. In laboratories, it is a safe, versatile workhorse used to create sustainable chemicals and clean up pollution. Yet, in hospital settings, it has recently emerged as a formidable pathogen, capable of causing severe infections in the most vulnerable patients.

Historically, P. putida was categorized as a low-virulence pathogen and was rarely associated with serious human disease. Because it is generally less virulent and more susceptible to antibiotics than its relative, Pseudomonas aeruginosa, it has been a preferred host for research. The FDA has even certified the KT2440 strain as safe for use in labs without extra precautions. This reputation as a 'safe' organism stems from its robust metabolism and its ability to degrade organic solvents like toluene, which led to it becoming the first patented living organism in the world.

However, the clinical landscape is shifting. Recent data from a study at Chonnam National University Hospital (2005–2011) revealed that multidrug-resistant (MDR) and carbapenem-resistant strains of P. putida are causing difficult-to-treat nosocomial infections. In a cohort of 18 patients with P. putida bacteremia, 39% died within 30 days. The infection was frequently linked to medical devices, with 77% of cases involving indwelling devices like central venous catheters, endotracheal tubes, or biliary stents. The primary infection sites included central venous catheters (39%), ventilator-associated pneumonia (22%), and the biliary tract (11%).

The danger lies in its environmental adaptability. P. putida can colonize moist, inanimate hospital surfaces, allowing it to persist in healthcare environments. While it remains a vital tool in the bioeconomy—used to produce biosurfactants from CO2-derived acetate and synthesize compounds like lycopene—its emergence as a resistant pathogen highlights a growing concern in clinical microbiology. It serves as a reminder that even 'low-virulence' organisms can become significant threats when they acquire the ability to resist potent antibiotics like imipenem and meropenem.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Pseudomonas bacteria are nature's most versatile survivors, from cloud-forming ice to hospital threats.
• This opportunistic bacterium thrives in hospital equipment and can even survive on soap.
• Klebsiella pneumoniae is a common soil dweller that can turn deadly in clinical settings.
• The slippery superbug hiding in your gut that threatens the future of modern medicine
• These resilient rod-shaped bacteria can survive extreme conditions that destroy most other life forms.
• The hidden complexity of shale gas extraction and its environmental footprint
• The divergent health trajectories of two distinct Pakistani American elder groups
• The ancient microbes that breathe sulfate and eat industrial waste
• The genetic reality of Rwanda defies centuries of colonial myth
• Nature's biological hacks can override your instincts with exaggerated signals
• How heavy metals quietly dismantle bacterial defenses at the molecular level
• A political thriller's massive success sparked a stylometric literary debate

More in Bacteria · More in Health · Latest · A–Z · All topics